Dr. Michael A. Carducci is a medical oncologist affiliated with Sibley Memorial Hospital. He is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine, as well as the Associate Cancer Center Director for Clinical Research within the Johns Hopkins Kimmel Cancer Center and the Regional Research Director for the National Capital Region for the Kimmel Cancer Center.
Dr. Carducci has an expertise in various types of cancer including bladder, kidney, prostate and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology.
A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital.
A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his laboratory and clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He is the Chair of the Genitourinary Oncology Committee of ECOG-ACRIN and an active member of the GU Steering Committee for the NCI. Dr. Carducci is Co-Chair of the Investigational Drug Steering Committee for the NCI and an Associate Editor for GU Cancers for the Journal of Clinical Oncology.
A translational researcher, Dr. Carducci directs a small laboratory program focused on bringing small molecules into early phase clinical trials. Overall, his laboratory and clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care.
This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida.